Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanisms of osteolytic and osteoblastic skeletal lesions.
David Roodman G, Silbermann R. David Roodman G, et al. Among authors: silbermann r. Bonekey Rep. 2015 Oct 28;4:753. doi: 10.1038/bonekey.2015.122. eCollection 2015. Bonekey Rep. 2015. PMID: 26539296 Free PMC article. Review.
Mechanisms of multiple myeloma bone disease.
Galson DL, Silbermann R, Roodman GD. Galson DL, et al. Among authors: silbermann r. Bonekey Rep. 2012 Aug 1;1:135. doi: 10.1038/bonekey.2012.135. eCollection 2012. Bonekey Rep. 2012. PMID: 23951515 Free PMC article.
Preclinical animal models of multiple myeloma.
Lwin ST, Edwards CM, Silbermann R. Lwin ST, et al. Among authors: silbermann r. Bonekey Rep. 2016 Feb 3;5:772. doi: 10.1038/bonekey.2015.142. eCollection 2016. Bonekey Rep. 2016. PMID: 26909147 Free PMC article.
Myeloma bone disease: Pathophysiology and management.
Silbermann R, Roodman GD. Silbermann R, et al. J Bone Oncol. 2013 Apr 18;2(2):59-69. doi: 10.1016/j.jbo.2013.04.001. eCollection 2013 Jun. J Bone Oncol. 2013. PMID: 26909272 Free PMC article. Review.
Bone effects of cancer therapies: pros and cons.
Silbermann R, Roodman GD. Silbermann R, et al. Curr Opin Support Palliat Care. 2011 Sep;5(3):251-7. doi: 10.1097/SPC.0b013e328349c524. Curr Opin Support Palliat Care. 2011. PMID: 21768880 Review.
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.
Storti P, Marchica V, Airoldi I, Donofrio G, Fiorini E, Ferri V, Guasco D, Todoerti K, Silbermann R, Anderson JL, Zhao W, Agnelli L, Bolzoni M, Martella E, Mancini C, Campanini N, Noonan DM, Petronini PG, Neri A, Aversa F, Roodman GD, Giuliani N. Storti P, et al. Among authors: silbermann r. Leukemia. 2016 Dec;30(12):2351-2363. doi: 10.1038/leu.2016.137. Epub 2016 May 20. Leukemia. 2016. PMID: 27311934
XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation Suppression.
Adamik J, Silbermann R, Marino S, Sun Q, Anderson JL, Zhou D, Xie XQ, Roodman GD, Galson DL. Adamik J, et al. Among authors: silbermann r. Front Endocrinol (Lausanne). 2018 Jun 29;9:344. doi: 10.3389/fendo.2018.00344. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30008697 Free PMC article.
Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo.
Teramachi J, Silbermann R, Yang P, Zhao W, Mohammad KS, Guo J, Anderson JL, Zhou D, Feng R, Myint KZ, Maertz N, Beumer JH, Eiseman JL, Windle JJ, Xie XQ, Roodman GD, Kurihara N. Teramachi J, et al. Among authors: silbermann r. Leukemia. 2016 Feb;30(2):390-8. doi: 10.1038/leu.2015.229. Epub 2015 Aug 19. Leukemia. 2016. PMID: 26286116 Free PMC article.
55 results